
Longevity Health Holdings, Inc. (XAGE)
Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
Market Cap
$3.3M
Revenue
$50K
P/E Ratio
N/A
P/B Ratio
-37.13
D/E Ratio
-0.14
Dividend Yield
0.00%
Updated: June 5 at 05:49:40